KLF4 and neoplasm: Taken together, DYRK2, as a tumor suppressor, may induce apoptosis via the p53 phosphorylation and suppression of c-Myc expression and regulate cell stemness through an inhibitory interaction with KLF4 in leukemia (Figure 4).